4,4'-Diaminodiphenyl sulphone: solubility and distribution in blood.
作者信息
LINDERSTROM-LANG C U, NAYLOR R F
出版信息
Biochem J. 1962 Jun;83(3):417-20. doi: 10.1042/bj0830417.
Abstract
摘要
相似文献
1
4,4'-Diaminodiphenyl sulphone: solubility and distribution in blood.4,4'-二氨基二苯砜：在血液中的溶解度与分布
Biochem J. 1962 Jun;83(3):417-20. doi: 10.1042/bj0830417.
2
4,4'-Diaminodiphenyl sulphone: binding to serum albumin.4,4'-二氨基二苯砜：与血清白蛋白的结合
Biochem J. 1962 Jun;83(3):420-4. doi: 10.1042/bj0830420.
3
Nuclear derivatives of 4:4-diaminodiphenyl sulphone.
J Pharm Pharmacol. 1950 Dec;2(12):937-43. doi: 10.1111/j.2042-7158.1950.tb13014.x.
4
The identification of the major diazotizable metabolite of 4:4'-diaminodiphenyl sulphone in rabbit urine.兔尿中4,4'-二氨基二苯砜主要可重氮化代谢物的鉴定。
Biochem J. 1956 Jul;63(3):406-8. doi: 10.1042/bj0630406.
5
[Diaminodiphenyl sulphone (DDS) therapy of dermatitis herpetiformis].
Ned Tijdschr Geneeskd. 1953 Apr 25;97(17):1064-8.
6
Urinary infections due to 4, 4'-diaminodiphenyl sulphone therapy: report of three cases.
Br J Dermatol. 1957 Jan;69(1):25-7. doi: 10.1111/j.1365-2133.1957.tb13765.x.
7
A fluorometric method for the simultaneous determination of 4,4'-diaminodiphenyl sulfone (DDS), N-acetyl-DDS (MADDS) and N,N'-diacetyl-DDS (DADDS) in serum or urine.
Int J Lepr Other Mycobact Dis. 1969 Oct-Dec;37(4):398-405.
8
The melting point of 4:4'diaminodiphenyl sulphone (dapsone).
J Pharm Pharmacol. 1953 Aug;5(8):568. doi: 10.1111/j.2042-7158.1953.tb14020.x.
9
[Treatment of leprosy with succinyl-diaminodiphenyl-sulfone].
Bull Mem Soc Med Hop Paris. 1950 May;66(15-16):653-9.
10
Preliminary report on 4:4' diaminodiphenyl sulfone (DDS) treatment of leprosy.
Int J Lepr. 1950 Jul-Sep;18(3):299-308.
引用本文的文献
1
4,4'-Diaminodiphenyl sulphone: binding to serum albumin.4,4'-二氨基二苯砜：与血清白蛋白的结合
Biochem J. 1962 Jun;83(3):420-4. doi: 10.1042/bj0830420.
2
N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.
Naunyn Schmiedebergs Arch Pharmacol. 1973;278(1):55-68. doi: 10.1007/BF00501863.
本文引用的文献
1
BINDING OF SULFONAMIDES BY PLASMA PROTEINS.磺胺类药物与血浆蛋白的结合
Science. 1942 Jan 16;95(2455):78. doi: 10.1126/science.95.2455.78.
2
Sulphanilamide inhibition of carbonic anhydrase in whole blood.
J Physiol. 1948 Mar 15;107(2):203-9. doi: 10.1113/jphysiol.1948.sp004263.
3
4
Antibacterial action and metabolism of five sulphones.五种砜类化合物的抗菌作用与代谢
Br J Pharmacol Chemother. 1950 Dec;5(4):565-83. doi: 10.1111/j.1476-5381.1950.tb00608.x.
5
Osmotic properties of living cells.活细胞的渗透特性。
Int Rev Cytol. 1959;8:387-448. doi: 10.1016/s0074-7696(08)62736-9.
6
[Study of the surface properties of erythrocytes in relation to sulfonamides distribution in blood].
Cas Lek Cesk. 1958 Feb 14;97(6-7):220-6.
7
Autoradiographic detection of sulphone in the affected tissues of leprosy patients.
Nature. 1957 Oct 26;180(4591):854-5. doi: 10.1038/180854b0.
8
Preferential uptake of sulphone by affected skin tissue of leprosy patients as detected by a tracer method.
Nature. 1956 Oct 13;178(4537):799-800. doi: 10.1038/178799b0.
9
[Adsorption of sulfanilic acid, sulfanilamide and sulfaethylthiodiazole on plasma proteins and their influence on distribution processes. V. Dynamics of distribution].
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;226(1):36-45.
10
[Biochemical studies on cyanosis following sulfonamides; distribution of sulfonamides in the blood].
Cas Lek Cesk. 1954 Jun 4;93(22-23):584-91.
Zotero 插件